Post-exposure prophylaxis with favipiravir among household close contacts to confirmed COVID-19 cases: A cluster-randomized trial (PEPfavi)
FPV-PEP was associated with a lower incidence of fever, rhinorrhea, and myalgia among household contacts. While a reduction in secondary transmission was observed, it did not reach statistical significance. Further large-scale studies are warranted to clarify its role in preventing household transmission.
Authors
- Saowanee Wongpatcharawarakul (ORCID: https://orcid.org/0000-0002-2591-2845)
- Kunsuda Cheirsilpa
- Marisa Muadchimkaew (ORCID: https://orcid.org/0000-0003-1753-7157)
- Kriangkrai Tawinprai (ORCID: https://orcid.org/0000-0002-2862-948X)
- Worrawat Sangwipasnapaporn (ORCID: https://orcid.org/0000-0003-3090-0811)
- Taweegrit Siripongboonsitti (ORCID: https://orcid.org/0000-0001-7256-9982)
- T. Ungtrakul
- Kamonwan Soonklang (ORCID: https://orcid.org/0000-0002-8053-2984)
- Krongkwan Niemsorn
- Nithi Mahanonda
- Natcha Wattanapokasilp
Institutions
- Chulabhorn Hospital (TH)
Publication Details
- Journal
- Journal of Infection and Public Health
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1016/j.jiph.2026.103150
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00